Skip to main content
Figure 4 | BMC Cancer

Figure 4

From: Enhanced NFκB and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer

Figure 4

Comparison of drug treatment effects on ER and ER binding to the transcriptional co-repressor, NCoR, in TAM-resistant (MCF7/HER2, BT474) and TAM-sensitive (MCF7) breast cancer cells. Cell cultures were treated for 24 h with vehicle, PS341 (panel A), or PA (panel B), alone or in combination with TAM (500 nM). Whole cells were then extracted and Western blotted to detect total ER relative to β-actin, or immunoprecipitated (IP) and then Western blotted (WB) to detect NCoR-bound ER relative to total immunoprecipitated NCoR.

Back to article page